An analysis by Gartner predicts that capital spending by manufacturers in all areas of the semiconductor industry will increase 7.1% to $62.27 billion in 2014. Spending declined 1.2% in 2013 to $58.0 billion. Within capital spending, spending on capital equipment and on wafer-fab equipment will grow by 15.0% and 16.1% to $38.5 billion and $31.7 […]

Earlier this month, the Codex Alimentarius Commission, run by the World Health Organization and the United Nations’ Food and Agriculture Organization, agreed on several new recommendations for food safety. Codex influences food standards of the 186 participating nations, although the countries have not enacted the recommendations into law yet. One decision was that eight veterinary […]

Companies providing lab-testing and associated services form an important segment of analytical instrument demand. Such firms advance analytical developments and work with private and public entities to implement testing requirements and conduct R&D. IBO spoke with three testing firms to gain insight into current demand and the trends affecting their businesses. A provider of inspections, […]

The US Patent and Trademark Office (PTO) has proposed new patent guidelines for natural products and processes, raising concern that the standard is too strict. The revised guidelines follow two Supreme Court decisions involving Prometheus Laboratories and Myriad Genetics that denied patents based on the patent code’s forbiddance of patenting “laws of nature, natural phenomena […]

Last month, the FDA issued three final guidance documents and one draft guidance for the use of nanotechnology in the products it regulates. “Final Guidance for Industry: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology” supplies a framework for regulation, listing two Points to Consider under either of which a product may be […]

First quarter revenues for the IBO Lab Equipment/Consumables Index grew 1.3%, 2.2% excluding currency, to $4,186 million. Adjusted operating profit advanced 5.1% to $766 million. Based on continuing operations, operating margin for the Index expanded 60 basis points to 16.7% of sales. For the fiscal first quarter ending February 28, sales for Gerresheimer Life Science […]

Based on public company data, revenues for biotech companies in established biotech centers (defined as the US, Europe, Canada and Australia) grew 10.1% last year to $98.8 billion. However, nearly all of this growth was due to 17 US “commercial leaders” (defined as firms with over $500 million in sales). Total biotech R&D spending rose […]

Although many medical schools are now offering genomic sequencing to patients with rare diseases, insurance reimbursement is still doubtful. The Medical College of Wisconsin has sequenced over 36 whole genome and 400 whole exomes. Baylor College of Medicine has sequenced 3,500 exomes and reported that of 250 cases of whole-exome sequencing, the genetic cause of […]

Oncology is a dynamic and diverse market. In 2017, oncology is estimated to lead all therapeutic areas in medicine spending (excluding supportive care) by developed nations, with revenues of $74–$84 billion. In pharmerging nations, it will to be the fourth-largest area, with $17–$20 billion in revenues. In 2013, global sales of oncology drugs totaled $37.2 […]